323 related articles for article (PubMed ID: 22773875)
1. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
3. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors.
Khaiboullina SF; Morzunov SP; Boichuk SV; Palotás A; St Jeor S; Lombardi VC; Rizvanov AA
Virology; 2013 Sep; 443(2):338-48. PubMed ID: 23830076
[TBL] [Abstract][Full Text] [Related]
4. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
5. PML plays both inimical and beneficial roles in HSV-1 replication.
Xu P; Mallon S; Roizman B
Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
[TBL] [Abstract][Full Text] [Related]
6. Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription site.
Newhart A; Negorev DG; Rafalska-Metcalf IU; Yang T; Maul GG; Janicki SM
Mol Biol Cell; 2013 May; 24(9):1454-68. PubMed ID: 23485562
[TBL] [Abstract][Full Text] [Related]
7. TTRAP is a novel PML nuclear bodies-associated protein.
Xu GL; Pan YK; Wang BY; Huang L; Tian L; Xue JL; Chen JZ; Jia W
Biochem Biophys Res Commun; 2008 Oct; 375(3):395-8. PubMed ID: 18706885
[TBL] [Abstract][Full Text] [Related]
8. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
[TBL] [Abstract][Full Text] [Related]
9. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
Catez F; Picard C; Held K; Gross S; Rousseau A; Theil D; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2012; 8(8):e1002852. PubMed ID: 22912575
[TBL] [Abstract][Full Text] [Related]
10. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
11. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
12. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
13. Two-step colocalization of MORC3 with PML nuclear bodies.
Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
[TBL] [Abstract][Full Text] [Related]
14. Dual roles for lysine 490 of promyelocytic leukemia protein in the transactivation of glucocorticoid receptor-interacting protein 1.
Liu ST; Lu GY; Hsu YJ; Chang LC; Ho CL; Huang SM
Biochim Biophys Acta; 2013 Aug; 1833(8):1799-810. PubMed ID: 23542129
[TBL] [Abstract][Full Text] [Related]
15. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
Salsman J; Wang X; Frappier L
Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
[TBL] [Abstract][Full Text] [Related]
16. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
Maroui MA; Pampin M; Chelbi-Alix MK
J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
[TBL] [Abstract][Full Text] [Related]
20. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
